The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

A therapeutic strategy for treating cancer is to target and eradicate cancer stem cells (CSCs) without harming their normal stem cell counterparts. The success of this approach relies on identification of molecular pathways that selectively regulate CSC function. Using BCR-ABL-induced chronic myeloi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Haojian, Peng, Cong, Hu, Yiguo, Li, Huawei, Sheng, Zhi, Chen, Yaoyu, Sullivan, Con, Cerny, Jan, Hutchinson, Lloyd, Higgins, Anne, Miron, Patricia, Zhang, Xueqing, Brehm, Michael, Li, Dongguang, Green, Michael R., Li, Shaoguang
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3408839/
https://ncbi.nlm.nih.gov/pubmed/22797726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ng.2350
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars